Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and Bioprocessing Applications with Optical Genome ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and ...
Bionano Genomics, which has commercialized a genome analysis platform used in laboratories across the world, is acquiring software firm BioDiscovery in a $90 million deal intended to broaden the reach ...
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the pricing of (i) $45.0 million aggregate principal amount of senior secured convertible notes due ...
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better ...
26 different customers representing North America, Asia and Europe 33 oral presentations across four consecutive days 69 scientific posters will be featured in a virtual exhibition hall Topics span ...
Bionano Genomics, Inc. today announced the Stratys ™ system for high throughput optical genome mapping (OGM) and VIA ™ software for visualization, interpretation and reporting of genome analysis for ...
Hard-hit biotech stocks rallied during the first month of 2023. This cohort of equities, however, couldn't sustain their momentum this week. What's behind this sudden trend reversal? From a macro ...
Life sciences equipment manufacturer Bionano Genomics (NASDAQ:BNGO) was a popular meme stock last year. Consequently, its management raised a massive amount of cash through equity offerings. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results